Physical and Chemical Stability Study of Morphine Sulfate Syrup
Main Article Content
Abstract
The purpose of this study was to evaluate the physical and chemical stability of morphine sulfate syrup in a concentration of 2 mg/ml, that was prepared by the division of pharmacy, Sappasithiprasong Hospital, Ubon Ratchathani Province. The 2 batches of morphine syrup preparations were kept at 4±1°C, 28±1°C, 37±1°C and 45±1°C, and then the physical and chemical stability were tested initially and periodically for 10 months. The changes in physical characters such as color, odor and particle precipitation were assessed by observation. The pH of the samples was measured by pH meter. The chemical stability of the preparation was evaluated by using HPLC analytical technique. It was found that morphine sulfate syrup stored at 4±1°C, 28±1°C, 37±1°C and 45±1°C were physically and chemically stable regarding color and odor. The pH of the samples were unchanged compared with those of the initial. In addition, all test samples remained free of visible particles throughout the study. The remained drug amounts of samples at 4 storage temperatures were more than 90%. However, the microbiological stability and preservative effectiveness tests should have been included in this study in order to ensure the efficacy and safety of drug use.
Article Details
In the case that some parts are used by others The author must Confirm that obtaining permission to use some of the original authors. And must attach evidence That the permission has been included
References
Connors KA, Amidon GL, Stella VJ. 1986. Chemical stability of pharmaceuticals: A Handbook for pharmacists, Wiley-Interscience, New York, pp. 604-611.
Nguyen-Xuan T, Griffiths W., et al. 2006. Stability of morphine sulfate in polypropylene infusion bags for use in patient-controlled analgesia pumps for postoperative pain management. In J Pharm Compounding 10(1): 69-73.
Preechagoon D, Sumyai V. et al. 2005. Formulation development and stability testing of oral morphine solution utilizing preformulation approach. J Pharm Pharmaceut Sci 8(2): 362-369.
The United States Pharmacopeia 29 and National Formulary NF 24. 2006. The United States Pharmacopeial Convention, Inc., Rockville, pp. 1460-1461.
Vermeire A, Remon JP. 1999. Stability and compatibility of morphine. Int J Pharm 187: 17-51.
WHO. 1996. Cancer pain relief: a guide to opioid availability from http://www.painpolicy.wisc.edu/publicat/cprguid.htm.